From rodent models to human insight.
Our advanced in silico tools reduce the need for animal testing and bring drug innovation closer to patients. From predicting preclinical toxicity to finding new opportunities for shelved drugs, R2H transforms how medicines are discovered, evaluated, and safely delivered to market.